The Coupon Comeback

In this down economy we’re seeing one trend making a comeback: Coupons. Last year coupon-redemption gained 23 percent–the first gain in nearly two decades. Before our current recession we saw many people dismissing the discounts, citing they were too much trouble. But the tough economic climate isn’t the only thing bringing them back into popularity.

Yez, please! First car with negative footprint is a dream for China

Imagine a car that has a negative carbon footprint.  In China, a new concept car called the  2030 Yez is the first automobile that promises to remove more pollution from the air than it creates. It’s an electric car that also combines several other technologies. The photo looks like something out of this world, doesn’t

Oct 2010: Candy & Snack TODAY

The New Consumer: How Shopping Has Changed For Good Candy & Snack TODAY, September/October 2010 Cheryl Perkins, founder and president of Innovationedge, LLC, a brand consultancy, expands on this notion: “Private label continues to be a focus for innovation. We’re seeing retailers figuring out how to deliver quality products while still maintaining lower prices for

Oct 2010: Candy & Snack TODAY

The New Consumer: How Shopping Has Changed For Good Candy & Snack TODAY, September/October 2010 Cheryl Perkins, founder and president of Innovationedge, LLC, a brand consultancy, expands on this notion: “Private label continues to be a focus for innovation. We’re seeing retailers figuring out how to deliver quality products while still maintaining lower prices for

A Hotbed for Biotechnology Innovation

Today  I am over  at San Diego State University where I’m teaching executive MBA classes. Along with cities like Madison, Austin, Raleigh Durham and Boston, San Diego is a key player in a field that may be more of a hotbed for innovation than any other: biotechnology. Genetic engineering, genomics, and molecular drug development are just a few of the industry terms that we are all becoming familiar with.

It’s an exciting environment here in San Diego. We’re anchored by research institutions and universities such the Salk Institute, Scripps Research Institute, University of California-San Diego, and hundreds of biotechnology firms, this could be the biological Silicon Valley for the 21st century.

With unequaled potential, the industry is still trying to prove it’s financial viability. This is because of many factors, but mostly it’s because it is researching the unknown and results can’t be predicted.

For example, in biopharmaceuticals, research for a new drug can take 10 years or more and cost more than $1 billion before any revenue is realized. On top of that it only takes one adverse study or regulation problem along the way to tip the scales between incredible income and huge losses.

Was a Nobel Laureate Initimidated into Not Filing a Patent for Graphene?

A number of people have commented about a recent story on Andre Geim, the inventor of graphene and new Nobel Laureate in physics, and his decision to not pursue a patent. One widely read recent tweet linked to a discussion on Slashdot that allegedly “Puts the lie to the claim that patents help small inventors.”